I have had the privilege of working with Leslie Mulkey, an independent video producer on a short "You Tube" video about Provenge. Our hope is that our question, "Should terminally ill patients have access to promising new therapies?" will become a part of the next national presidential debate. You can view our video by clicking [...]
General cancer research has made great strides over the last few years. Over this past year, we have seen the first major advance in twenty years in kidney cancer; new treatment options for breast cancer, targeted therapies for head and neck cancers as well as a novel gene profiling test that can predict which patients [...]
Often, the FDA limits access to clinical trials to patients who have failed all other approved therapies. This means that we only evaluate potential new drugs on individuals who are already very sick and have been weakened by their disease as well as their prior treatments. Cancer cells "learn" how to survive treatments by mutating. [...]
President Bush signs a proclamation declaring our nations support for our fight with Prostate Cancer. Sadly, these are only empty words as once again all cancer research, including prostate cancer research, has taken a real dollar hit! George Bush and our congress don't really care. I guess that they all view themselves as invulnerable. Someone [...]
The Life Extension Foundation has a series of "Alerts", one of which is about the problems at the FDA that I have been writing about recently. If you go to their alert web page at www.lef.org/lac you can have the following letter electronically sent to your individual congressperson (Senators and House Representative). It will take [...]